EAS Familial Hypercholesterolaemia Studies CollaborationVallejo-Vaz, Antonio J.De Marco, MartinaStevens, Christophe A.T.Akram, AsifFreiberger, TomasHovingh, G. KeesKastelein, John J.P.Mata, PedroRaal, Frederick J.Santos, Raul D.Soran, HandreanWatts, Gerald F.Abifadel, MarianneAguilar-Salinas, Carlos A.Al-Khnifsawi, MutazAlKindi, Fahad A.Alnouri, FahadAlonso, RodrigoAl-Rasadi, KhalidAl-Sarraf, AhmadAshavaid, Tester F.Binder, Christoph J.Bogsrud, Martin P.Bourbon, MafaldaBruckert, EricChlebus, KrzysztofCorral, PabloDescamps, OlivierDurst, RonenEzhov, MaratFras, ZlatkoGenest, JacquesGroselj, UrhHarada-Shiba, MarikoKayikcioglu, MeralLalic, KatarinaLam, Carolyn S.P.Latkovskis, GustavsLaufs, UlrichLiberopoulos, EvangelosLin, JieMaher, VincentMajano, NelsonMarais, A. DavidMärz, WinfriedMirrakhimov, ErkinMiserez, André R.Mitchenko, OlenaNawawi, Hapizah M.Nordestgaard, Børge G.Paragh, GyörgyPetrulioniene, ZanetaPojskic, BelmaPostadzhiyan, ArmanReda, AshrafReiner, ŽeljkoSadoh, Wilson E.Sahebkar, AmirhosseinShehab, AbdullahShek, Aleksander B.Stoll, MarioSu, Ta-ChenSubramaniam, TavintharanSusekov, Andrey V.Symeonides, PhivosTilney, MyraTomlinson, BrianTruong, Thanh-HuongTselepis, Alexandros D.Tybjærg-Hansen, AnneVázquez-Cárdenas, AlejandraViigimaa, MargusVohnout, BranislavWidén, ElisabethYamashita, ShizuyaBanach, MaciejGaita, DanJiang, LixinNilsson, LennartSantos, Lourdes E.Schunkert, HeribertTokgözoğlu, LaleCar, JosipCatapano, Alberico L.Ray, Kausik K.Hypercholesterolaemia Studies Collaboration (FHSC) Investigators2018-10-182018-10-182018-10Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.0021-9150http://hdl.handle.net/10400.18/5621EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) investigators - Portugal: Mafalda Bourbon (NLI), Ana C. Alves, Ana M. Medeiros (Unidade I&D, Grupo de Investigação Cardiovascular, Dept. de Promoção da Saúde e Doenças Não Transmissíveis, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa; University of Lisboa, Faculty of Sciences, BioISI – Biosystems & Integrative Sciences Institute, Lisboa).Management of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey among the worldwide network of EAS FHSC Lead Investigators to provide an overview of FH status in different countries.Highlights: The EAS FHSC is an international initiative involving a network of investigators interested in FH from around 70 countries; Information on FH prevalence is lacking in most countries; where available, data tend to align with contemporary estimates; FH diagnosis and management varies widely across countries, with overall suboptimal identification and under-treatment; In most countries diagnosis primarily relies on DLCN criteria, and less frequently on Simon Broom or MEDPED; Therapy for FH is not universally reimbursed, and criteria vary across countries. Access to PCSK9i and apheresis is limited.engFHSCFamilial HypercholesterolaemiaPrimary DyslipidaemiaDoenças Cardio e Cérebro-vascularesjournal article10.1016/j.atherosclerosis.2018.08.051